GHELARDONI, SANDRA
 Distribuzione geografica
Continente #
NA - Nord America 9.783
AS - Asia 4.486
EU - Europa 3.878
SA - Sud America 510
Continente sconosciuto - Info sul continente non disponibili 187
AF - Africa 163
OC - Oceania 17
Totale 19.024
Nazione #
US - Stati Uniti d'America 9.471
IT - Italia 1.429
SG - Singapore 1.378
CN - Cina 1.355
HK - Hong Kong 663
SE - Svezia 621
BR - Brasile 420
DE - Germania 384
VN - Vietnam 345
BG - Bulgaria 282
CA - Canada 241
GB - Regno Unito 207
TR - Turchia 206
UA - Ucraina 165
FR - Francia 160
FI - Finlandia 141
RU - Federazione Russa 122
JP - Giappone 116
AT - Austria 100
KR - Corea 97
IN - India 96
CI - Costa d'Avorio 82
CH - Svizzera 79
BD - Bangladesh 44
NL - Olanda 38
PL - Polonia 33
AR - Argentina 31
IQ - Iraq 29
MX - Messico 29
SA - Arabia Saudita 24
BE - Belgio 23
ID - Indonesia 20
MA - Marocco 19
CO - Colombia 18
ES - Italia 16
PK - Pakistan 16
AU - Australia 15
SN - Senegal 14
ZA - Sudafrica 14
CZ - Repubblica Ceca 13
GR - Grecia 13
UZ - Uzbekistan 11
MY - Malesia 10
NG - Nigeria 10
DK - Danimarca 9
EC - Ecuador 9
VE - Venezuela 9
CR - Costa Rica 8
JO - Giordania 8
AE - Emirati Arabi Uniti 7
IR - Iran 7
PH - Filippine 7
RO - Romania 7
AF - Afghanistan, Repubblica islamica di 6
CL - Cile 6
JM - Giamaica 6
KE - Kenya 6
LT - Lituania 6
NP - Nepal 6
PT - Portogallo 6
PY - Paraguay 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
EG - Egitto 5
GT - Guatemala 5
KZ - Kazakistan 5
NI - Nicaragua 5
PA - Panama 5
TN - Tunisia 5
AL - Albania 4
IL - Israele 4
OM - Oman 4
UY - Uruguay 4
AZ - Azerbaigian 3
BO - Bolivia 3
BY - Bielorussia 3
EU - Europa 3
IE - Irlanda 3
NO - Norvegia 3
BJ - Benin 2
DZ - Algeria 2
EE - Estonia 2
HR - Croazia 2
KW - Kuwait 2
LB - Libano 2
NZ - Nuova Zelanda 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CG - Congo 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GY - Guiana 1
HU - Ungheria 1
Totale 18.828
Città #
Woodbridge 974
Ashburn 916
Singapore 828
Dallas 706
Ann Arbor 661
Hong Kong 647
Chandler 583
San Jose 546
Milan 531
Houston 514
Santa Clara 506
Fairfield 452
Shanghai 349
Sofia 281
Beijing 261
Jacksonville 238
New York 205
Wilmington 204
Council Bluffs 188
Ottawa 179
Cambridge 154
Seattle 154
Los Angeles 147
Serra 147
Boardman 140
Izmir 131
Princeton 127
Nanjing 124
Hefei 110
Lawrence 109
Tokyo 103
Lauterbourg 99
Ho Chi Minh City 92
Seoul 87
Vienna 85
Abidjan 82
Frankfurt am Main 79
Medford 74
Rome 73
Dong Ket 67
Bern 65
Istanbul 58
Florence 57
Pisa 57
London 54
Dearborn 53
Des Moines 52
Buffalo 51
Bremen 49
Hanoi 48
Redwood City 48
Jüchen 45
São Paulo 39
Munich 37
Chicago 35
Orem 34
Redondo Beach 34
Nanchang 33
Helsinki 32
San Diego 30
Kunming 29
Boulder 28
Columbus 28
Pune 25
Brussels 22
The Dalles 22
Atlanta 21
Falls Church 21
Nuremberg 21
Chennai 20
Warsaw 20
Lancaster 19
Montreal 19
Tianjin 19
Changsha 18
Shenyang 17
Washington 17
Brooklyn 16
San Francisco 16
Ogden 15
Renton 15
Turku 15
Dakar 14
Düsseldorf 14
Livorno 14
Lucca 14
Norwalk 14
Phoenix 14
Hebei 13
Jiaxing 13
Amsterdam 12
Boston 12
Hangzhou 12
Stockholm 12
Baghdad 11
Casablanca 11
Da Nang 11
Fuzhou 11
Guangzhou 11
Jakarta 11
Totale 13.531
Nome #
EFFECTS OF ALTERED GRAVITY ON STEM CELL BIOLOGY AND TISSUE REGENERATION IN THE PRESENCE OF CERIUM OXIDE NANOPARTICLES 263
Exogenous 3-iodothyronamine rescues the entorhinal cortex from β-amyloid toxicity 255
Assay of endogenous 3,5-diiodo-L-thyronine (3,5-T2) and 3,3’-diiodo-L-thyronine (3,3’-T2) in human serum: a feasibility study 226
Development and primary characterization of a human thyroid organoid in vitro model for thyroid metabolism investigation 219
3-Iodothyronamine modulates sarcoplasmic reticulum calcium release 207
Modulation of L-type calcium channel expression by sarcoplasmic reticulum calcium release 207
S-nitrosothiol detection in isolated perfused rat heart 207
Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart 205
3-Iodothyronamine as a novel endogenous chemical messenger: tissue distribution and catabolism 205
Effect of MEN 10755, a new disaccharide analogue of doxorubicin, on sarcoplasmic reticulum Ca(2+) handling and contractile function in rat heart 205
Stimulation of cardiac trace amine receptors by 3-iodothyronamine modulates tyrosine phosphorylation and induces cardioprotection 204
Cardioprotective effect of 3-iodothyronamine in perfused rat heart subjected to ischemia and reperfusion. 203
Effects of 3-iodothyronamine (T1AM) on signaling pathways involved in synaptic plasticity and neuroprotection. 201
Stimulation of cardiac trace amine receptors by 3-iodothyronamine modulates tyrosine phosphorylation and induces cardioprotection 196
Exercise pulmonary hypertension in chronic thromboembolic pulmonary disease without resting pulmonary hypertension: A systematic review and meta-analysis 194
Cardioprotection by 3-iodothyronamine, a new endogenous chemical messenger 189
3-Iodothyronamine as a Novel Endogenous Chemical Messenger: Tissue Distribution and Catabolism. 189
3-iodothyronamine as a potential anti-tumor compound 189
Preconditioning by adenosine is associated with increased sarcoplasmic reticulum phospholamban expression 188
Modulation of sarcoplasmic reticulum calcium channel by adenosine: a PKC-dependent pathway 187
3-Iodothyronamine (T(1)AM) induces variation in phosphorylation pattern of tyrosine residues in rat heart 186
Metabolic reprogramming by 3-Iodothyronamine (T1AM): a new perspective to reverse obesity through co-regulation of sirtuin 4 and 6 expression 183
Empagliflozin inhibits excessive autophagy through the AMPK/GSK3β signaling pathway in diabetic cardiomyopathy 182
A1 adenosine receptor stimulates phospholamban expression 182
Farmaci antineoplastici e tossicità cardiovascolare 180
WEIGHT LOSS WITH PRESERVED GLUCOSE HOMEOSTASIS DURING CHRONIC TREATMENT OF OBESE MICE WITH 3-IODOTHYRONAMINE (T1AM): ROLE OF THE SIRTUIN FAMILY 179
Topiramate does not alter expression in rat brain of enzymes of arachidonic acid metabolism 178
Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors 178
Cardioprotective effect of growth hormone secretagogues in rat heart 177
A new signalling pathway mediated by 3-iodothyronamine in rat heart 175
A3 adenosine receptor stimulation modulates sarcoplasmic reticulum Ca2+ release in rat heart 175
3-iodothyronamine (T1AM) induces changes on glutamatergic postsynaptic signaling pathway 175
3-Iodothyronamine Modulates Sarcoplasmic Reticulum Calcium Release 174
Modulation of Cardiac Inotropic State by 3-Iodothyronamine: Evidence for a Novel Signalling Pathway Mediated by Trace Amine-Associated Receptors 174
Effects of Zofenopril on Cardiac Sarcoplasmic Reticulum Calcium Handling 174
Characterization of 3-Iodothyronamine In Vitro Dynamics by Mathematical Modeling 174
Cardioprotection by ranolazine in perfused rat heart 174
Assay of endogenous 3,5-diiodo-L-thyronine (3,5-T2) and 3,3’-diiodo-L-thyronine (3,3’-T2) in human serum. 173
Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors. 172
Deciphering the potential of 3-iodothyronamine (T1AM) in regulating lipid metabolism 171
Effects of A1 adenosine receptor stimulation on the expression of genes involved in calcium homeostasis 170
Cardioprotective effect of growth hormone secretagogues in rat heart 168
3-Iodothyronamine (T1AM) modifies tyrosine phosphorylation pattern in rat heart 167
Cardiac effects of trace amines: Pharmacological characterization of trace amine-associated receptors 167
3,5-diiodo-L-thyronine increases glucose consumption in cardiomyoblasts without affecting the contractile performance in rat heart 166
Evaluation of 3-iodothyronamine (T1AM) in cell preparation, tissue homogenates and biological fluids by HPLC-ESI-MS-MS 165
Vascular Progenitor Cells: From Cancer to Tissue Repair 163
Artificially altered gravity elicits cell homeostasis imbalance in planarian worms, and cerium oxide nanoparticles counteract this effect 162
A1 receptor stimulation induces changes in calcium homeostasis 161
3-Iodothyronamine (T1AM) signalling pathway involves tyrosine phosphorylation in rat heart 160
Tissue Distribution and Cardiac Metabolism of 3-Iodothyronamine 160
3-Iodothyronamine (T1AM) induces variation in the phosphorylation pattern of thyrosine residues in rat heart 159
3-Iodothyronamine and 3,5,3’-triiodo-L-thyronine reduce SIRT1 protein expression in HepG2 cell line. 158
Cardioprotective effect of zofenopril in perfused rat heart subjected to ischemia and reperfusion 156
Cardiac effects of thyronamines 156
Cardiac metabolism of 3-iodothyronamine 155
Recovery of 3-iodothyronamine and derivatives in biological matrices: problems and pitfalls 155
Modulation of cardiac calcium homeostasis by 3-iodothyronamine 155
Modulation of the cardiac sarcoplasmic reticulum release by adenosine: a protein kinase C-dependent pathway 154
Modulation of cardiac inotropic state by 3-iodothyronamine: evidence for a novel signalling pathway mediated by trace amine-associated receptors 152
Cross-talk” between L-type sarcolemmal calcium channels and sarcoplasmic reticulum calcium release channels in rat myocardium 151
New insights into the thyroid endocrine system by HPLC-ESI-MS-MS 150
Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function 149
Effects of 3-Iodothyronamine on Sarcoplasmic Reticulum Calcium Release in Rat Heart 148
Preconditioning by adenosine is associated with increased sarcoplasmic reticulum phopsholamban expression 146
Effect of 3-iodothyronamine on myocardial calcium homeostasis 146
Ca2+ channel remodelling in perfused heart: effects of mechanical work and interventations affecting Ca2+ cycling on sarcolemmal and sarcoplasmic reticulum Ca2+ channels 146
Ca2+-induced remodeling of Ca2+ channels in myocardium 145
Ghrelin tissue distribution: comparison between gene and protein expression 143
3-iodothyronamine is a novel endogenous modulator of cardiac function 142
Cardioprotection and energy metabolism modulation by 3-iodothyronamine, a new endogenous chemical messanger 142
Up-take of thyronines and 3-iodothyronamine in liver cells 142
Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain 142
Effects of 3-iodothyronamine (T1AM) on long term potentiation (LTP) postsynaptic signaling cascade 142
Chronic carbamazepine decreases the expression and the activity of cytosolic phospholipase A2 in rat brain 141
3-Iodothyronamine cardiac metabolism: new insights resulting from liquid chromatography tandem mass spectrometry analysis 141
Short-term effects of pressure overload on the expression of genes involved in calcium homeostasis 141
Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat 141
Cardiac Functional Effects of 3-Iodothyronamine, a New Endogenous Thyroid Hormone Derivative 140
New insights into 3-iodothyronamine (T1AM) cardiac metabolism by LC/MS/MS 138
Effects of 3,5-diiodo-L-thyronine on the cardiac tissue 138
3-Iodothyronamine cardiac metabolism: new insights resulting from liquid chromatography tandem mass spectrometry analysis 137
Biochemical basis of ischemic heart injury and of cardioprotective interventions 137
A3 adenosine receptor stimulation modulates sarcoplasmic reticulum calcium release, 136
Modulation of sarcoplasmic reticulum calcium channel by adenosine: a PKC-dependent pathway 136
Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart 136
T1AM A MASTER REGULATOR AND A POTENTIAL DRUG OF SIRTUIN PROTEINS: APPLICATIONS TO AGING AND CANCER 136
Modulation of calcium channel expression in rat myocardium by work load 135
Empagliflozin restores autophagy and attenuates ponatinib-induced cardiomyocyte senescence and death 133
Uptake and metabolic effects of 3-iodothyronamine (T1AM) in hepatocytes 133
Cardiovascular outcomes and molecular targets for the cardiac effects of Sodium-Glucose Cotransporter 2 Inhibitors: A systematic review 132
Late preconditioning by adenosine is associated with reduced sarcoplasmic reticulum calcium uptake 131
Detecting 3-iodothyronamine in the presence of fetal bovine serum: isotope kinetic effect and other pitfalls 131
La biochimica di Thomas M. Devlin 128
Vasostatins: new molecular targets for atherosclerosis, post-ischaemic angiogenesis, and arteriogenesis 126
Empagliflozin mitigates ponatinib-induced cardiotoxicity by restoring the connexin 43-autophagy pathway 125
Cardioprotection by A3 adenosine agonists: role of sarcoplasmic reticulum calcium release 125
Empaglifozin alleviates diabetic cariomyopathy via inhibiting excessive autophagy and adverse remodelling in type I diabetic mice. 124
Selective downregulation of brain cytosolic phospholipase A2 activity and protein in rats treated chronically with carbamazepine 124
Cardioprotection by 3-iodothyronamine, a new endogenous chemical messanger 124
Totale 16.387
Categoria #
all - tutte 51.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.676


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.119 0 83 23 56 220 160 29 46 53 51 90 308
2022/20231.732 223 243 130 191 189 224 8 107 283 8 94 32
2023/20241.515 218 198 186 128 241 245 43 41 30 27 38 120
2024/20253.697 38 173 41 162 397 302 388 207 357 526 447 659
2025/20264.507 229 568 492 531 417 387 712 175 272 328 219 177
2026/2027630 165 465 0 0 0 0 0 0 0 0 0 0
Totale 19.024